Relational Dynamics of Treatment Behavior Among Individuals with Tuberculosis in High-Income Countries: A Scoping Review

References

• Lienhardt C, Glaziou P, Uplekar M, Lönnroth K, Getahun H, Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol. 2012;10(6):407–416. doi:10.1038/nrmicro2797
   PubMed Web of Science ®Google Scholar
• Fears R, Kaufmann S, Ter Meulen V, Zumla A, Group EW. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Tuberculosis. 2010;90(3):182–187. doi:10.1016/j.tube.2010.03.008
   Web of Science ®Google Scholar
• World Health Organization. Global health observatory data repository. 2020. Available from: https://apps.who.int/gho/data/node.main.1315?lang=en. Accessed September 13, 2020.
   Google Scholar
• World Health Organization. Framework towards tuberculosis elimination in low-incidence countries; 2014. Available from: https://www.who.int/tb/publications/elimination_framework/en/. Accessed September 26, 2020.
   Google Scholar
• World Health Organization. Global tuberculosis report 2019; 2019. Available from: https://www.who.int/teams/global-tuberculosis-programme/global-report-2019. Accessed September 26, 2020.
   Google Scholar
• World Bank. World Bank country and lending groups; 2020. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed September 26, 2020.
   Google Scholar
• Gupta RK, Lipman M, Story A, et al. Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era. Int J Tuberc Lung Dis. 2018;22(5):479–487. doi:10.5588/ijtld.17.0767
   PubMed Web of Science ®Google Scholar
• Heuvelings CC, de Vries SG, Grobusch MP. Tackling TB in low-incidence countries: improving diagnosis and management in vulnerable populations. Int J Infect Dis. 2017;56:77–80.
   Web of Science ®Google Scholar
• Public Health England. Tackling tuberculosis in under-served populations: a resource for TB control boards and their partners; 2019. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773730/Tackling_TB_in_Under-Served_Populations_-_a_Resource_for_TBCBs_and_partners.pdf. Accessed December 20, 2020.
   Google Scholar
• Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar J-W. Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J Infect. 2018;77(6):469–478. doi:10.1016/j.jinf.2018.10.004
   PubMed Web of Science ®Google Scholar
• Anderson C, Anderson SR, Maguire H, Hayward AC, Story A. Tuberculosis in London: the convergence of clinical and social complexity. Eur Respir J. 2016;48(4):1233–1236. doi:10.1183/13993003.00749-2016
   Web of Science ®Google Scholar
• Stagg HR, Flook M, Martinecz A, et al. All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era. ERJ Open Res. 2020;6(4):00315–2020. doi:10.1183/23120541.00315-2020
   PubMedGoogle Scholar
• Jones ASK, Bidad N, Horne R, et al. Determinants of non-adherence to anti-TB treatment in high income, low TB incidence settings: a scoping review. Int J Tuberc Lung Dis.
   Web of Science ®Google Scholar
• Mason PH, Degeling C. Beyond biomedicine: relationships and care in tuberculosis prevention. J Bioethical Inq. 2016;13(1):31–34. doi:10.1007/s11673-015-9697-6
   Web of Science ®Google Scholar
• Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238–e238. doi:10.1371/journal.pmed.0040238
   PubMed Web of Science ®Google Scholar
• Horne R, Cooper V, Wileman V, Chan A. Supporting adherence to medicines for long-term conditions: a perceptions and practicalities approach based on an extended common-sense model. Eur Psychol. 2019;24(1):82–96. doi:10.1027/1016-9040/a000353
   Web of Science ®Google Scholar
• Pradipta IS, Houtsma D, van Boven JFM, Alffenaar J-WC, Hak E. Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. Npj Prim Care Respir Med. 2020;30(1):21. doi:10.1038/s41533-020-0179-x
   Web of Science ®Google Scholar
• Amico KR, Mugavero M, Krousel-Wood MA, Bosworth HB, Merlin JS. Advantages to using social-behavioral models of medication adherence in research and practice. J Gen Intern Med. 2018;33(2):207–215. doi:10.1007/s11606-017-4197-5
   PubMed Web of Science ®Google Scholar
• World Health Organization. The end TB strategy: global strategy and targets for tuberculosis prevention, care and control after 2015; 2015. Available from: https://www.who.int/tb/post2015_strategy/en/. Accessed September 13, 2020.
   Google Scholar
• World Health Organization.Adherence to long-term therapies: evidence for action; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed May 29, 2020.
   Google Scholar
• Jaam M, Awaisu A, Mohamed Ibrahim MI, Kheir N. A holistic conceptual framework model to describe medication adherence in and guide interventions in diabetes mellitus. Res Soc Adm Pharm. 2018;14(4):391–397. doi:10.1016/j.sapharm.2017.05.003
   Web of Science ®Google Scholar
• National Institute for Health Care Excellence. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical guideline CG76; 2009. Available from: https://www.nice.org.uk/Guidance/CG76. Accessed March 18, 2021.
   Google Scholar
• Kielmann K, Vidal N, Riekstina V, et al. Treatment is of primary importance, and social assistance is secondary: a qualitative study on the organisation of tuberculosis (TB) care and patients’ experience of starting and staying on TB treatment in Riga, Latvia. PLoS One. 2018;13(10):e0203937. doi:10.1371/journal.pone.0203937
   Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications: new taxonomy for adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. doi:10.1080/1364557032000119616
   Google Scholar
• Craig GM, Zumla A. The social context of tuberculosis treatment in urban risk groups in the United Kingdom: a qualitative interview study. Int J Infect Dis. 2015;32:105–110. doi:10.1016/j.ijid.2015.01.007
   Web of Science ®Google Scholar
• Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Des Jarlais DC. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep. 1994;109(3):319–327.
   PubMed Web of Science ®Google Scholar
• Kawatsu L, Uchimura K, Ohkado A, Kato S. A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan – are physicians and nurses at a particular risk?. PLoS One. 2018;13(6):e0198075. doi:10.1371/journal.pone.0198075
   Web of Science ®Google Scholar
• Pujol-Cruells A, Vilaplana C. Specific interventions for implementing a patient-centered approach to TB care in low-incidence cities. Front Med. 2019;6:273. doi:10.3389/fmed.2019.00273
   Web of Science ®Google Scholar
• Shiratani KN. Psychological changes and associated factors among patients with tuberculosis who received directly observed treatment short-course in metropolitan areas of Japan: quantitative and qualitative perspectives. BMC Public Health. 2019;19(1):1642. doi:10.1186/s12889-019-8001-9
   Web of Science ®Google Scholar
• Grace J, Chenhall R. A rapid anthropological assessment of tuberculosis in a remote aboriginal community in Northern Australia. Hum Organ. 2006;65(4):387–399. doi:10.17730/humo.65.4.69egxry83x2v03r8
   Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Gerrish K, Naisby A, Ismail M. Experiences of the diagnosis and management of tuberculosis: a focused ethnography of Somali patients and healthcare professionals in the UK. J Adv Nurs. 2013;69(10):2285–2294. doi:10.1111/jan.12112
   PubMed Web of Science ®Google Scholar
• Searle A, Park J, Littleton J. Alliance and compliance in tuberculosis treatment of older Pakeha people in Auckland, New Zealand. Int J Tuberc Lung Dis. 2007;11(1):72–77.
   Web of Science ®Google Scholar
• Moffatt J, Mayan M, Long R. Sanitoriums and the Canadian colonial legacy. Qual Health Res. 2013;23(12):1591–1599. doi:10.1177/1049732313508843
   Web of Science ®Google Scholar
• Macdonald ME, Rigillo N, Brassard P. Urban aboriginal understandings and experiences of tuberculosis in Montreal, Quebec, Canada. Qual Health Res. 2010;20(4):506–523. doi:10.1177/1049732309360538
   Web of Science ®Google Scholar
• Wannheden C, Westling K, Savage C, Sandahl C, Ellenius J. HIV and tuberculosis coinfection: a qualitative study of treatment challenges faced by care providers. Int J Tuberc Lung Dis. 2013;17(8):1029–1035. doi:10.5588/ijtld.12.0446
   Web of Science ®Google Scholar
• Nnoaham KE, Pool R, Bothamley G, Grant AD. Perceptions and experiences of tuberculosis among African patients attending a tuberculosis clinic in London. Int J Tuberc Lung Dis. 2006;10(9):1013–1017.
   Web of Science ®Google Scholar
• Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald JM. Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes. 2004;2(58):58. doi:10.1186/1477-7525-2-58
   Google Scholar
• Gibson N, Cave A, Doering D, Ortiz L, Harms P. Socio-cultural factors influencing prevention and treatment of tuberculosis in immigrant and aboriginal communities in Canada. Soc Sci Med. 2005;61(5):931–942. doi:10.1016/j.socscimed.2004.10.026
   Web of Science ®Google Scholar
• Wieland ML, Weis JA, Yawn BP, et al. Perceptions of tuberculosis among immigrants and refugees at an adult education center: a community-based participatory research approach. J Immigr Minor Health. 2012;14(1):14–22. doi:10.1007/s10903-010-9391-z
   PubMed Web of Science ®Google Scholar
• Joseph HA, Waldman K, Rawls C, Wilce M, Shrestha-Kuwahara R. TB perspectives among a sample of Mexicans in the United States: results from an ethnographic study. J Immigr Minor Health. 2008;10(2):177–185. doi:10.1007/s10903-007-9067-5
   Web of Science ®Google Scholar
• Konradsen H, Lillebaek T, Wilcke T, Lomborg K. Being publicly diagnosed: a grounded theory study of Danish patients with tuberculosis. Int J Qual Stud Health Well-Being. 2014;9(1):23644. doi:10.3402/qhw.v9.23644
   PubMed Web of Science ®Google Scholar
• Sagbakken M, Bjune GA, Frich JC. Humiliation or care? A qualitative study of patients’ and health professionals’ experiences with tuberculosis treatment in Norway: humiliation or care? Scand J Caring Sci. 2012;26(2):313–323. doi:10.1111/j.1471-6712.2011.00935.x
   Web of Science ®Google Scholar
• Zuniga JA, Munoz SE, Johnson MZ, Garcia A. Tuberculosis treatment for Mexican Americans living on the U.S.-Mexico border. J Nurs Scholarsh. 2014;46(4):253–262. doi:10.1111/jnu.12071
   PubMed Web of Science ®Google Scholar
• Yamada S, Caballero J, Matsunaga DS, Agustin G, Magana M. Attitudes regarding tuberculosis in immigrants from the Philippines to the United States. Fam Med. 1999;31(7):477–482.
   Google Scholar
• van der Oest C, Chenhall R, Hood D, Kelly P. Talking about TB: multicultural diversity and tuberculosis services in Waikato, New Zealand. N Z Med J. 2005;118(1216):62–72.
   Google Scholar
• Kulane A, Ahlberg BM, Berggren I. “It is more than the issue of taking tablets”: the interplay between migration policies and TB control in Sweden. Health Policy (New York). 2010;97(1):26–31. doi:10.1016/j.healthpol.2010.02.014
   Web of Science ®Google Scholar
• Craig GM, Joly LM, Zumla A. ‘Complex’ but coping: experience of symptoms of tuberculosis and health care seeking behaviours - a qualitative interview study of urban risk groups, London, UK. BMC Public Health. 2014;14(1):618. doi:10.1186/1471-2458-14-618
   Web of Science ®Google Scholar
• Komarnisky S, Hackett P, Abonyi S, Heffernan C, Long R. “Years ago”: reconciliation and first nations narratives of tuberculosis in the Canadian Prairie Provinces. Crit Public Health. 2016;26(4):381–393. doi:10.1080/09581596.2015.1067672
   Web of Science ®Google Scholar
• Boudioni M, McLaren S, Belling R, Woods L. Listening to those on the frontline: service users’ experiences of London tuberculosis services. Patient Prefer Adherence. 2011;5:267–277. doi:10.2147/PPA.S20361
   Web of Science ®Google Scholar
• Solar O, Irwin A. A conceptual framework for action on the social determinants of health. Social determinants of health discussion paper 2 (policy and practice). World Health Organization; 2010. Available from: https://apps.who.int/iris/bitstream/handle/10665/44489/9789241500852_eng.pdf?sequence=1&isAllowed=y. Accessed January 22, 2021.
   Google Scholar
• Karat AS, Jones AS, Abubakar I, et al. “You have to change your whole life”: a qualitative study of the dynamics of treatment adherence among adults with tuberculosis in the United Kingdom. J Clin Tuberc Mycobact Dis. 2021;23:100233 doi:10.1016/j.jctube.2021.100233.
   Google Scholar
• Vernon A, Fielding K, Savic R, Dodd L, Nahid P. The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials. PLOS Med. 2019;16(12):e1002884. doi:10.1371/journal.pmed.1002884
   Web of Science ®Google Scholar
• Stagg HR, Abubakar I, Campbell CN, et al. IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial. BMJ Open. 2019;9:e032760.
   Web of Science ®Google Scholar
• Sagbakken M, Frich JC, Bjune GA, Porter JD. Ethical aspects of directly observed treatment for tuberculosis: a cross-cultural comparison. BMC Med Ethics. 2013;14:25. doi:10.1186/1472-6939-14-25
   Web of Science ®Google Scholar
• Kelly P. Isolation and stigma: the experience of patients with active tuberculosis. J Community Health Nurs. 1999;16(4):233–241. doi:10.1207/S15327655JCHN1604_3
   PubMedGoogle Scholar
• Kielmann K, Vidal N, Karat AS, Stagg HR, Lipman M, on behalf of the IMPACT study group (NIHR 16/88/06). Supporting adherence to treatment for tuberculosis (TB): a relational view. Int J Tuberc Lung Dis. 2019;22(11):S385.
   Google Scholar